Analysis reveals FLT3-ITD influences immune evasion by altering T cell and NK cell profiles in acute myeloid leukemia.
Key Points
FLT3-ITD mutation leads to impaired differentiation and activation of immune cells, allowing leukemic cells to evade detection.
Significant reduction of cytotoxic NK cell populations was identified, associated with immature phenotypes in both mouse and human models.
Multiparametric flow cytometry of AML samples showed distinct immunophenotypes related to FLT3 and NPM1 mutation status, impacting treatment resistance.
Findings highlight the role of leukemic differentiation in immune escape, suggesting new avenues for targeted immunotherapy.